evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

173 questions · 173 findings · 16 reviews · Hepato-Biliary

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 15 · 8.7%GRADE not reported 4 · 2.3%Very low 100 · 57.8%Low 42 · 24.3%Moderate 11 · 6.4%High 1 · 0.6%

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

All‐cause mortality at 30 days · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

All‐cause mortality at 5 years · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Reintervention Number of women with reintervention · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes number of participants with reintervention at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Irreversible shunt occlusion at 5 years · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes irreversible shunt occlusion at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Encephalopathy · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes number of participants with encephalopathy at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

All‐cause mortality · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Serious adverse events · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes serious adverse events compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Encephalopathy · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes encephalopathy compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Ascites · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes ascites compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Any re‐intervention · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes any re‐intervention compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review